AAAAAA

   
Results: 1-11 |
Results: 11
A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected Thai subjects with CD4-cell counts of > 300 (vol 7, pg 728, 2000)
Authors: Churdboonchart, V Sakondhavat, C Kulpradist, S Ayudthya, BIN Chandeying, V Rugpao, S Boonshuyar, C Sukeepaisarncharoen, W Sirawaraporn, W Carlo, DJ Moss, R
Citation: V. Churdboonchart et al., A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected Thai subjects with CD4-cell counts of > 300 (vol 7, pg 728, 2000), CL DIAG LAB, 8(6), 2001, pp. 1295-1295
Effectiveness of remune - Authors' reply
Authors: Churdboonchart, V Sirawaraporn, W Boonshuyar, C Sakondhavat, C Sukeepaisarncharoen, W Kulpradist, S Ayudthya, BIN Chandeying, V Rugpao, S
Citation: V. Churdboonchart et al., Effectiveness of remune - Authors' reply, CL DIAG LAB, 8(2), 2001, pp. 469-469
A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected Thai subjects with CD4-Cell counts of > 300
Authors: Churdboonchart, V Sakondhavat, C Kulpradist, S Isarangkura, B Ayudthya, BIN Chandeying, V Rugpao, S Boonshuyar, C Sukeepaisarncharoen, W Sirawaraporn, W Carlo, DJ Moss, R
Citation: V. Churdboonchart et al., A double-blind, adjuvant-controlled trial of human immunodeficiency virus type 1 (HIV-1) immunogen (Remune) monotherapy in asymptomatic, HIV-1-infected Thai subjects with CD4-Cell counts of > 300, CL DIAG LAB, 7(5), 2000, pp. 728-733
Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: Structural basis of antifolate resistance
Authors: Rastelli, G Sirawaraporn, W Sompornpisut, P Vilaivan, T Kamchonwongpaisan, S Quarrell, R Lowe, G Thebtaranonth, Y Yuthavong, Y
Citation: G. Rastelli et al., Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: Structural basis of antifolate resistance, BIO MED CH, 8(5), 2000, pp. 1117-1128
Antimalarial drug development and new targets
Authors: Macreadie, I Ginsburg, H Sirawaraporn, W Tilley, L
Citation: I. Macreadie et al., Antimalarial drug development and new targets, PARASIT TOD, 16(10), 2000, pp. 438-444
Crystal structure of Mycobacterium tuberculosis 6-hydroxymethyl-7,8-dihydropteroate synthase in complex with pterin monophosphate: New insight into the enzymatic mechanism and sulfa-drug action (vol 302, pg 1193, 2000)
Authors: Baca, AM Sirawaraporn, R Turley, S Sirawaraporn, W Hol, WGJ
Citation: Am. Baca et al., Crystal structure of Mycobacterium tuberculosis 6-hydroxymethyl-7,8-dihydropteroate synthase in complex with pterin monophosphate: New insight into the enzymatic mechanism and sulfa-drug action (vol 302, pg 1193, 2000), J MOL BIOL, 303(5), 2000, pp. 843-843
Crystal structure of Mycobacterium tuberculosis 6-hydroxymethyl-7,8-dihydropteroate synthase in complex with pterin monophosphate: New insight into the enzymatic mechanism and sulfa-drug action
Authors: Baca, AM Sirawaraporn, R Turley, S Sirawaraporn, W Hol, WGJ
Citation: Am. Baca et al., Crystal structure of Mycobacterium tuberculosis 6-hydroxymethyl-7,8-dihydropteroate synthase in complex with pterin monophosphate: New insight into the enzymatic mechanism and sulfa-drug action, J MOL BIOL, 302(5), 2000, pp. 1193-1212
Three-dimensional structure of M-tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs
Authors: Li, RB Sirawaraporn, R Chitnumsub, P Sirawaraporn, W Wooden, J Athappilly, F Turley, S Hol, WGJ
Citation: Rb. Li et al., Three-dimensional structure of M-tuberculosis dihydrofolate reductase reveals opportunities for the design of novel tuberculosis drugs, J MOL BIOL, 295(2), 2000, pp. 307-323
Development of a lead inhibitor for the A16V+S108T mutant of dihydrofolatereductase from the cycloguanil-resistant strain (T9/94) of Plasmodium falciparum
Authors: Yuthavong, Y Vilaivan, T Chareonsethakul, N Kamchonwongpaisan, S Sirawaraporn, W Quarrell, R Lowe, G
Citation: Y. Yuthavong et al., Development of a lead inhibitor for the A16V+S108T mutant of dihydrofolatereductase from the cycloguanil-resistant strain (T9/94) of Plasmodium falciparum, J MED CHEM, 43(14), 2000, pp. 2738-2744
Cloning and expression of Mycobacterium tuberculosis and Mycobacterium leprae dihydropteroate synthase in Escherichia coli
Authors: Nopponpunth, V Sirawaraporn, W Greene, PJ Santi, DV
Citation: V. Nopponpunth et al., Cloning and expression of Mycobacterium tuberculosis and Mycobacterium leprae dihydropteroate synthase in Escherichia coli, J BACT, 181(21), 1999, pp. 6814-6821
Dihydrofolate reductase and antifolate resistance in mal aria
Authors: Sirawaraporn, W
Citation: W. Sirawaraporn, Dihydrofolate reductase and antifolate resistance in mal aria, DRUG RESIST, 1(6), 1998, pp. 397-406
Risultati: 1-11 |